| Catalogue Number | Name of the Impurity | Molecular Formula | Molecular Weight | CAS Number | Structure |
|---|---|---|---|---|---|
| OXL-IMP-A0013 | Abiraterone Impurity 10 |
C24H31NO |
349.52 | 165334-72-5 | 
|
| OXL-IMP-A0012 | Abiraterone Impurity 9 |
C26H33NO2 |
391.56 | 165334-69-0 | 
|
| OXL-IMP-A0011 | Abiraterone Impurity 8 |
C19H27IO |
398.33 | 32138-69-5 | 
|
| OXL-IMP-A0010 | Abiraterone Impurity 7 |
C23H34O2 |
342.53 | 2118-32-3 | 
|
| OXL-IMP-A0009 | Abiraterone Impurity 6 |
C24H29N |
331.50 | 154229-20-6 | 
|
| OXL-IMP-A0008 | Abiraterone Impurity 5 |
C22H29F3O5S |
462.52 | 115375-60-5 | 
|
| OXL-IMP-A0007 | Abiraterone Impurity 4 |
C23H33NO3 |
371.52 | 2174-13-2 | 
|
| OXL-IMP-A0006 | Abiraterone Impurity 3 |
C20H27F3O4S |
420.49 | 124643-35-2 | 
|
| OXL-IMP-A0005 | Abiraterone Impurity 2 |
C23H32O3 |
356.51 | 979-02-2 | 
|
| OXL-IMP-A0004 | Abiraterone Impurity 1 |
C24H30NO5SNa |
467.56 | 1993430-24-2 (free acid) | 
|
| OXL-IMP-A0003 | Abiraterone Acetate N-Oxide |
C26H33NO3 |
407.55 | NA | |
| OXL-IMP-A0002 | Abiraterone |
C24H31NO |
349.52 | 154229-19-3 | 
|
| OXL-IMP-A0001 | Abiraterone Acetate |
C26H33NO2 |
391.56 | 154229-18-2 | 
|
| Catalogue Number | Name of the Impurity | Molecular Formula | Molecular Weight | CAS Number | Structure |
| Catalogue Number | Name of the Impurity | Molecular Formula | Molecular Weight | CAS Number | Structure |
|---|---|---|---|---|---|
| OXL-IMP-A0038 | Adefovir Dipivoxil Imp 7 | C15H24N5O6P | 401.36 | 1875153-79-9 | 
|
| OXL-IMP-A0037 | Adefovir Dipivoxil Imp 6 | C19H30N5O7P | 471.45 | 1416439-02-5 | 
|
| OXL-IMP-A0036 | Adefovir Dipivoxil Imp 5 | C25H40N5O9P | 585.59 | 1215101-40-8 | 
|
| OXL-IMP-A0035 | Adefovir Dipivoxil Imp 4 | C16H26N5O6P | 415.39 | 142341-04-6 | 
|
| OXL-IMP-A0034 | Adefovir Dipivoxil Imp 3 | C14H22N5O6P | 387.33 | 142341-05-7 | 
|
| OXL-IMP-A0033 | Adefovir Dipivoxil Imp 2 | C20H32N5O8P | 501.48 | 142340-99-6 | 
|
| OXL-IMP-A0032 | Adefovir Dipivoxil Imp 1 | C8H8D4N5O4P | 277.21 | 1190021-70-5 | 
|
| OXL-IMP-A0031 | Adefovir | C8H12N5O4P | 273.19 | 106941-25-7 | 
|
| Catalogue Number | Name of the Impurity | Molecular Formula | Molecular Weight | CAS Number | Structure |
| Catalogue Number | Name of the Impurity | Molecular Formula | Molecular Weight | CAS Number | Structure |
|---|---|---|---|---|---|
| OXL-IMP-A0075 | Anastrozole Impurity 14 | C15H17ClN2 | 260.77 | 120511-91-3 | 
|
| OXL-IMP-A0074 | Anastrozole Impurity 13 | C15H18N2O | 242.32 | 120511-88-8 | 
|
| OXL-IMP-A0073 | Anastrozole Impurity 12 | C15H17ClN2 | 260.77 | 120511-91-3 | 
|
| OXL-IMP-A0072 | Anastrozole Impurity 11 | C17H19N5 | 293.37 | 120511-92-4 | 
|
| OXL-IMP-A0071 | Anastrozole Impurity 10 | C15H18N2 | 226.32 | 120511-72-0 | 
|
| OXL-IMP-A0070 | Anastrozole Impurity 9 | C15H16Br2N2 | 384.12 | 1027160-12-8 | 
|
| OXL-IMP-A0069 | Anastrozole Impurity 8 | C15H17BrN2 | 305.22 | 120511-84-4 | 
|
| OXL-IMP-A0068 | Anastrozole Impurity 7 | C30H31N9 | 517.64 | 1216898-82-6 | 
|
| OXL-IMP-A0067 | Anastrozole Impurity 6 | C26H29N3 | 383.54 | 918312-71-7 | 
|
| OXL-IMP-A0066 | Anastrozole Impurity 5 | C11H10N2 | 170.22 | 120511-74-2 | 
|
| OXL-IMP-A0064 | Anastrozole Impurity 4 | C17H21N5O | 311.39 | 120512-03-0 | 
|
| OXL-IMP-A0063 | Anastrozole Impurity 2 | C17H23N5O2 | 329.40 | 120512-04-1 | 
|
| OXL-IMP-A0062 | Anastrozole Impurity 1 | C17H21N3O4 | 331.37 | 1338800-81-9 | 
|
| OXL-IMP-A0061 | Anastrozole | C17H19N5 | 293.37 | 120511-73-1 | 
|
| Catalogue Number | Name of the Impurity | Molecular Formula | Molecular Weight | CAS Number | Structure |
| Catalogue Number | Name of the Impurity | Molecular Formula | Molecular Weight | CAS Number | Structure |
|---|---|---|---|---|---|
| OXL-IMP-A0104 | Atazanavir Impurity 13 | C36H50N6O5 | 646.83 | 1192224-26-2 | 
|
| OXL-IMP-A0103 | Atazanavir Impurity 12 (4R,5S-Diasteroisomer of DI | C32H42N4O5 | 562.72 | 1006868-81-0 | 
|
| OXL-IMP-A0102 | Atazanavir Impurity 11 |
C17H21N3O2 |
299.37 | 198904-85-7 | 
|
| OXL-IMP-A0101 | Atazanavir Impurity 10 | C15H21NO3 | 263.34 | 98760-08-8 | 
|
| OXL-IMP-A0100 | Atazanavir EP Impurity J Atazanavir Impurity 9 | C32H42N4O5 | 562.71 | 198904-86-8 | 
|
| OXL-IMP-A0099 | Atazanavir Impurity 8 | C8H15NO4 | 189.21 | 162537-11-3 | 
|
| OXL-IMP-A0098 | Atazanavir Impurity 7 S,S,S,R-Diastereomer | C38H52N6O7 | 704.87 | 1332981-16-4 | 
|
| OXL-IMP-A0097 | Atazanavir Impurity 6 R,S,S,S-Diastereomer | C38H52N6O7 | 704.87 | 1332981-14-2 | 
|
| OXL-IMP-A0096 | Atazanavir Impurity 5 | C26H43N5O7 | 537.66 | 1192224-24-0 | 
|
| OXL-IMP-A0095 | Atazanavir Impurity 4 (Pyridinyl Benzaldehyde) | C12H9NO | 183.21 | 127406-56-8 | 
|
| OXL-IMP-A0094 | Atazanavir Impurity 3 (Pyridinyl Benzoic Acid) | C12H9NO2 | 199.21 | 4385-62-0 | 
|
| OXL-IMP-A0093 | Atazanavir Impurity 2 |
C22H26N4O3 HCl |
398.94 | 198904-87-9 | 
|
| OXL-IMP-A0092 | Atazanavir Impurity 1 | C38H52N6O7 | 704.87 | 1292296-09-3 | 
|
| OXL-IMP-A0091 | Atazanavir Sulphate | C38H52N6O7 | 704.87 | 198904-31-3 | 
|
| Catalogue Number | Name of the Impurity | Molecular Formula | Molecular Weight | CAS Number | Structure |
| Catalogue Number | Name of the Impurity | Molecular Formula | Molecular Weight | CAS Number | Structure |
|---|---|---|---|---|---|
| OXL-IMP-B0002 | Bictegravir-13C-15N-2D | 13 453.38 | 1611493-60-7 (non-labelled) | 
|
|
| OXL-IMP-B0001 | Bictegravir | C21H18F3N3O5 | 449.39 | 1611493-60-7 | 
|
| Catalogue Number | Name of the Impurity | Molecular Formula | Molecular Weight | CAS Number | Structure |
| Catalogue Number | Name of the Impurity | Molecular Formula | Molecular Weight | CAS Number | Structure |
|---|---|---|---|---|---|
| OXL-IMP-C0008 | Canagliflozin Impurity 7 | C24H25FO6S | 460.52 | 1951467-29-0 | 
|
| OXL-IMP-C0007 | Canagliflozin Impurity 6 | C24H23FO6S | 458.50 | 1951467-28-9 | 
|
| OXL-IMP-C0006 | Canagliflozin Impurity 5 | C10H7FS | 178.23 | 58861-48-6 | 
|
| OXL-IMP-C0005 | Canagliflozin Impurity 4 | C18H42O6Si4 | 466.87 | 32384-65-9 | 
|
| OXL-IMP-C0004 | Canagliflozin Impurity 3 | C6H10O6 | 178.14 | 90-80-2 | 
|
| OXL-IMP-C0003 | Canagliflozin Impurity 2 | C24H25FO5S | 444.53 | 1589590-87-3 | 
|
| OXL-IMP-C0002 | Canagliflozin Impurity 1 | C24H21FO5SD4 | 448.55 | 842133-18-0 | 
|
| OXL-IMP-C0001 | Canagliflozin | C24H25FO5S | 444.52 | 842133-18-0 | 
|
| Catalogue Number | Name of the Impurity | Molecular Formula | Molecular Weight | CAS Number | Structure |
| Catalogue Number | Name of the Impurity | Molecular Formula | Molecular Weight | CAS Number | Structure |
|---|---|---|---|---|---|
| OXL-IMP-C0046 | Capecitabine Impurity 9 | C11H14FN3O6 | 303.25 | 296248-49-2 | 
|
| OXL-IMP-C0045 | Capecitabine Impurity 8 | C11H16O7 | 260.24 | 62211-93-2 | 
|
| OXL-IMP-C0044 | Capecitabine Impurity 7 | C9H12FN3O4 | 245.21 | 71609-08-0 | 
|
| OXL-IMP-C0043 | Capecitabine Impurity 6 | C16H20FN3O7 | 385.35 | 921769-65-5 | 
|
| OXL-IMP-C0042 | Capecitabine Impurity 5 | C20H30FN3O9 | 475.48 | 1262133-68-5 | 
|
| OXL-IMP-C0041 | Capecitabine Impurity 4 | C20H30FN3O9 | 475.48 | 1262133-66-3 | 
|
| OXL-IMP-C0040 | Capecitabine Impurity 3 | C20H30FN3O9 | 475.48 | 1262133-64-1 | 
|
| OXL-IMP-C0039 | Capecitabine Impurity 2 | C9H11FN2O5 | 246.20 | 18771-50-1 | 
|
| OXL-IMP-C0038 | Capecitabine Impurity 1 | C9H11FN2O5 | 251.22 | 3094-09-5 (non-labeled) | 
|
| OXL-IMP-C0037 | Capecitabine EP Imp G | C19H26FN3O8 | 443.43 | 162204-20-8 | 
|
| OXL-IMP-C0036 | Capecitabine EP Imp E | C15H22FN3O6 | 359.35 | 162204-30-0 | 
|
| OXL-IMP-C0035 | Capecitabine EP Imp D | C15H22FN3O6 | 359.35 | 910129-15-6 | 
|
| OXL-IMP-C0034 | Capecitabine EP Imp C | C13H16FN3O6 | 329.28 | 161599-46-8 | 
|
| OXL-IMP-C0031 | Capecitabine | C15H22FN3O6 | 359.35 | 154361-50-9 | 
|
| Catalogue Number | Name of the Impurity | Molecular Formula | Molecular Weight | CAS Number | Structure |
| Catalogue Number | Name of the Impurity | Molecular Formula | Molecular Weight | CAS Number | Structure |
|---|---|---|---|---|---|
| OXL-IMP-C0063 | Transplatin | Cl2H6N2Pt | 300.05 | 14913-33-8 | 
|
| OXL-IMP-C0062 | Cisplatin Impurity 1 | [PtCl(H20)(NH3)2] | 282.61 | 53861-42-0 | 
|
| OXL-IMP-C0061 | Cisplatin | Cl2H6N2Pt | 300.05 | 15663-27-1 | 
|
| Catalogue Number | Name of the Impurity | Molecular Formula | Molecular Weight | CAS Number | Structure |
| Catalogue Number | Name of the Impurity | Molecular Formula | Molecular Weight | CAS Number | Structure |
|---|---|---|---|---|---|
| OXL-IMP-C0094 | Crisaborole m-Isomer | C14H10BNO3 | 251.05 | 906673-42-5 | 
|
| OXL-IMP-C0093 | Crisaborole o-Isomer | C14H10BNO3 | 251.05 | 906673-30-1 | 
|
| OXL-IMP-C0092 | Crisaborole-d4 | C14H6D4BNO3 | 255.07 | 906673-24-3 (non-labelled) | 
|
| OXL-IMP-C0091 | Crisaborole | C14H10BNO3 | 251.05 | 906673-24-3 | 
|
| Catalogue Number | Name of the Impurity | Molecular Formula | Molecular Weight | CAS Number | Structure |
| Catalogue Number | Name of the Impurity | Molecular Formula | Molecular Weight | CAS Number | Structure |
|---|---|---|---|---|---|
| OXL-IMP-D0030 | Darunavir Impurity 28 | C27H37N3O7S | 547.67 | 1402142-63-5 | 
|
| OXL-IMP-D0029 | Darunavir Impurity 27 | C21H27N3O4S | 417.52 | 1418639-27-6 | 
|
| OXL-IMP-D0028 | Darunavir Impurity 26 | C22H30N2O3 | 370.49 | 143224-62-8 | 
|
| OXL-IMP-D0027 | Darunavir Impurity 25 | C11H19NO6 | 261.28 | 156636-67-8 | 
|
| OXL-IMP-D0026 | Darunavir Impurity 24 | C7H10O4 | 158.15 | 866594-60-7 | 
|
| OXL-IMP-D0025 | Darunavir Impurity 23 | C7H10O4 | 158.15 | 1932353-11-1 | 
|
| OXL-IMP-D0024 | Darunavir Impurity 22 | C7H10O4 | 158.15 | 1932330-83-0 | 
|
| OXL-IMP-D0023 | Darunavir Impurity 21 | C7H10O4 | 158.15 | 866594-61-8 | 
|
| OXL-IMP-D0022 | Darunavir Impurity 20 | C20H29N3O3S | 391.53 | 192800-79-6 | 
|
| OXL-IMP-D0021 | Darunavir Impurity 19 | C22H31N3O5S | 449.57 | 1526916-57-3 | 
|
| OXL-IMP-D0020 | Darunavir Impurity 18 | C11H13NO7 | 271.23 | 253265-97-3 | 
|
| OXL-IMP-D0019 | Darunavir Impurity 17 | C20H29N3O3S | 391.53 | 1402142-62-4 | 
|
| OXL-IMP-D0018 | Darunavir Impurity 16 | C27H37N3O7S | 547.67 | 1399859-60-9 | 
|
| OXL-IMP-D0017 | Darunavir Impurity 15 | C20H29N3O3S | 391.53 | 169280-56-2 | 
|
| OXL-IMP-D0016 | Darunavir Impurity 14 | C25H35N3O7S | 521.64 | 1133153-38-4 | 
|
| OXL-IMP-D0015 | Darunavir Impurity 13 | C25H35N3O7S | 521.64 | 1005324-46-8 | 
|
| OXL-IMP-D0014 | Darunavir Impurity 12 | C13H13NO7 | 295.25 | 252873-00-0 | 
|
| OXL-IMP-D0013 | Darunavir Impurity 11 | C13H13NO7 | 295.25 | 252873-01-1 | 
|
| OXL-IMP-D0012 | Darunavir Impurity 10 | C13H13NO7 | 295.25 | 288296-64-0 | 
|
| OXL-IMP-D0011 | Darunavir Impurity 9 | C11H13NO7 | 271.23 | 799241-86-4 | 
|
| OXL-IMP-D0010 | Darunavir Impurity 8 | C11H13NO7 | 271.23 | 799241-85-3 | 
|
| OXL-IMP-D0009 | Darunavir Impurity 7 | C11H13NO7 | 271.23 | 253265-98-4 | 
|
| OXL-IMP-D0008 | Darunavir Impurity 6 | C29H43N3O8S | 593.74 | 635728-49-3 | 
|
| OXL-IMP-D0007 | Darunavir Impurity 5 | C33H45N3O13S | 723.80 | 1159613-27-0 | 
|
| OXL-IMP-D0006 | Darunavir Impurity 4 | C33H45N3O13S | 723.80 | 1159613-25-8 | 
|
| OXL-IMP-D0005 | Darunavir Impurity 3 | C27H37N3O8S | 563.67 | 1159613-24-7 | 
|
| OXL-IMP-D0004 | Darunavir Impurity 2 | C33H45N3O13S | 723.80 | 1159613-25-8 | 
|
| OXL-IMP-D0003 | Darunavir Impurity 1 | C27H37N3O8S | 563.67 | 1130635-75-4 | 
|
| OXL-IMP-D0002 | Darunavir-d9 | C27H28D9N3O7S | 556.72 | 1133378-37-6 | 
|
| OXL-IMP-D0001 | Darunavir | C27H37N3O7S | 547.68 | 206361-99-1 | 
|
| Catalogue Number | Name of the Impurity | Molecular Formula | Molecular Weight | CAS Number | Structure |
| Catalogue Number | Name of the Impurity | Molecular Formula | Molecular Weight | CAS Number | Structure |
|---|---|---|---|---|---|
| OXL-IMP-D0043 | Dasatinib Impurity 11 | C22H24ClN7O3S | 502.00 | 910297-53-9 | 
|
| OXL-IMP-D0042 | Dasatinib Impurity 10 | C22H26ClN7O3S | 504.01 | 910297-58-4 | 
|
| OXL-IMP-D0041 | Dasatinib Impurity 9 | C21H21Cl2N5O3S | 494.40 | 910297-70-0 | 
|
| OXL-IMP-D0040 | Dasatinib Impurity 8 | C22H27N7O3S | 469.56 | 1159977-25-9 | 
|
| OXL-IMP-D0039 | Dasatinib Impurity 7 | C22H26ClN7O3S | 504.01 | 910297-57-3 | 
|
| OXL-IMP-D0038 | Dasatinib Impurity 6 | C36H34Cl2N12O2S2 | 801.77 | 910297-61-9 | 
|
| OXL-IMP-D0037 | Dasatinib Impurity 5 | C24H28ClN7O3S | 530.05 | 1245157-85-0 | 
|
| OXL-IMP-D0036 | Dasatinib Impurity 4 | C22H27N7O2S | 453.57 | 1184919-23-0 | 
|
| OXL-IMP-D0035 | Dasatinib Impurity 3 | C16H13Cl2N5OS | 394.27 | 302964-08-5 | 
|
| OXL-IMP-D0034 | Dasatinib Impurity 2 | C11H10ClN3OS | 267.73 | 302964-24-5 | 
|
| OXL-IMP-D0033 | Dasatinib Impurity 1 | C20H22ClN7OS | 443.96 | 910297-51-7 | 
|
| OXL-IMP-D0032 | Dasatinib N-Oxide | C22H26ClN7O3S | 504.01 | 910297-52-8 | 
|
| OXL-IMP-D0031 | Dasatinib | C22H26ClN7O2S | 488.02 | 302962-49-8 | 
|
| Catalogue Number | Name of the Impurity | Molecular Formula | Molecular Weight | CAS Number | Structure |
| Catalogue Number | Name of the Impurity | Molecular Formula | Molecular Weight | CAS Number | Structure |
|---|---|---|---|---|---|
| OXL-IMP-D0065 | Dolutegravir Impurity 4 | C20H19F2N3O5 | 419.38 | 1357289-37-2 | 
|
| OXL-IMP-D0064 | Dolutegravir Impurity 3 | C20H19F2N3O5 | 419.38 | 1309560-49-3 | 
|
| OXL-IMP-D0063 | Dolutegravir Impurity 2 | C20H19F2N3O5 | 419.38 | 1357289-29-2 | 
|
| OXL-IMP-D0062 | Dolutegravir Impurity 1 | C20H14F2N3O5D5 | 424.42 | 1051375-16-6 | 
|
| OXL-IMP-D0061 | Dolutegravir Sodium | C20H19F2N3O5 | 419.38 | 1051375-16-6 | 
|
| Catalogue Number | Name of the Impurity | Molecular Formula | Molecular Weight | CAS Number | Structure |
| Catalogue Number | Name of the Impurity | Molecular Formula | Molecular Weight | CAS Number | Structure |
|---|---|---|---|---|---|
| OXL-IMP-E0020 | Efavirenz Impurity 20 | C22H17ClF3NO3 | 435.83 | 174819-21-7 | 
|
| OXL-IMP-E0019 | Efavirenz Impurity 19 | C21H19ClF3NO2 | 409.83 | 173676-60-3 | 
|
| OXL-IMP-E0018 | Efavirenz Impurity 18 | C21H17ClF3NO2 | 407.82 | 209414-26-6 | 
|
| OXL-IMP-E0017 | Efavirenz Impurity 17 | C14H9ClF3NO2 | 315.68 | 154598-52-4 | 
|
| OXL-IMP-E0016 | Efavirenz Impurity 16 | C14H9ClF3NO2 | 315.68 | 154801-74-8 | 
|
| OXL-IMP-E0015 | Efavirenz Impurity 15 | C13H11ClF3NO | 289.69 | 154598-58-0 | 
|
| OXL-IMP-E0014 | Efavirenz Impurity 14 | C14H9ClF3NO2 | 321.61 | 1261394-62-0 | 
|
| OXL-IMP-E0013 | Efavirenz Impurity 13 | C15H13ClF3NO3 | 347.72 | 211563-40-5 | 
|
| OXL-IMP-E0012 | Efavirenz Impurity 12 | C16H15ClF3NO3 | 361.75 | 211563-41-6 | 
|
| OXL-IMP-E0011 | Efavirenz Impurity 11 | C21H17ClF3NO3 | 423.82 | 1189491-03-9 | 
|
| OXL-IMP-E0010 | Efavirenz Impurity 10 | C14H11ClF3NO2 | 317.70 | 1627575-36-3 | 
|
| OXL-IMP-E0009 | Efavirenz Impurity 9 | C15H11ClF3NO2 | 329.71 | 1217623-65-8 | 
|
| OXL-IMP-E0008 | Efavirenz Impurity 8 | C15H11ClF3NO2 | 329.70 | 353270-76-5 | 
|
| OXL-IMP-E0007 | Efavirenz Impurity 7 | C14H9ClF3NO3 | 331.68 | 205754-32-1 | 
|
| OXL-IMP-E0006 | Efavirenz Impurity 6 | C14H9ClF3NO3 | 331.68 | 205754-33-2 | 
|
| OXL-IMP-E0005 | Efavirenz Impurity 5 | C13H9ClF3N | 271.67 | 391860-73-4 | 
|
| OXL-IMP-E0004 | Efavirenz Impurity 4 | C14H11ClF3NO2 | 317.69 | 440124-96-9 | 
|
| OXL-IMP-E0003 | Efavirenz Impurity 3 | C13H11ClF3NO | 289.69 | 209414-27-7 | 
|
| OXL-IMP-E0002 | Efavirenz Impurity 2 | C14H9ClF3NO2 | 315.68 | 177530-93-7 | 
|
| OXL-IMP-E0001 | Efavirenz Impurity 1 | C14H4D5ClF3NO2 | 320.71 | 177530-93-7 (non-labelled) | 
|
| Catalogue Number | Name of the Impurity | Molecular Formula | Molecular Weight | CAS Number | Structure |
| Catalogue Number | Name of the Impurity | Molecular Formula | Molecular Weight | CAS Number | Structure |
|---|---|---|---|---|---|
| OXL-IMP-E0033 | para-Hydroxy Elvitegravir | C23H23ClFNO6 | 463.89 | 870648-10-5 | 
|
| OXL-IMP-E0032 | Elvitegravir-d8 | C23H15ClFNO5D8 | 455.94 | 697761-98-1 | 
|
| OXL-IMP-E0031 | Elvitegravir | C23H23ClFNO5 | 447.89 | 697761-98-1 | 
|
| Catalogue Number | Name of the Impurity | Molecular Formula | Molecular Weight | CAS Number | Structure |
| Catalogue Number | Name of the Impurity | Molecular Formula | Molecular Weight | CAS Number | Structure |
|---|---|---|---|---|---|
| OXL-IMP-E0078 | Emtricitabine Imp 16 | C10H20O | 156.27 | 2216-51-5 | 
|
| OXL-IMP-E0077 | Emtricitabine Imp 15 | C8H12FN3O4S | 265.26 | 1994304-22-1 | 
|
| OXL-IMP-E0076 | Emtricitabine Imp 14 | C8H11N3O4S | 245.25 | 1238210-14-4 | 
|
| OXL-IMP-E0075 | Emtricitabine Imp 13 | C15H26O4S | 302.43 | 1091585-26-0 | 
|
| OXL-IMP-E0074 | Emtricitabine Imp 12 | C18H26FN3O4S | 399.48 | 764659-72-5 | 
|
| OXL-IMP-E0073 | Emtricitabine Imp 11 | C10H20O | 156.27 | 2216-52-6 | 
|
| OXL-IMP-E0072 | Emtricitabine Imp 10 | C10H20O | 156.27 | 20747-49-3 | 
|
| OXL-IMP-E0071 | Emtricitabine Imp 9 | C10H20O | 156.27 | 15356-60-2 | 
|
| OXL-IMP-E0070 | Emtricitabine Imp 8 | C10H20O | 156.27 | 20752-33-4 | 
|
| OXL-IMP-E0069 | Emtricitabine Imp 7 | C10H20O | 156.27 | 64282-88-8 | 
|
| OXL-IMP-E0068 | Emtricitabine Imp 6 | C10H20O | 156.27 | 23283-97-8 | 
|
| OXL-IMP-E0067 | Emtricitabine Imp 5 | C10H20O | 156.27 | 20752-34-5 | 
|
| OXL-IMP-E0066 | Emtricitabine Imp 4 | C8H10FN3O3S | 247.24 | 145416-34-8 | 
|
| OXL-IMP-E0065 | Emtricitabine Imp 3 | C8H9FN2O4S | 248.23 | 145281-92-1 | 
|
| OXL-IMP-E0064 | Emtricitabine Imp 2 | C8H10FN3O4S | 263.24 | 152128-77-3 | 
|
| OXL-IMP-E0063 | Emtricitabine Imp 1 | C8H8FN3O4S | 261.23 | 1238210-10-0 | 
|
| OXL-IMP-E0062 | Emtricitabine Enantiomer | C8H10FN3O3S | 247.24 | 137530-41-7 | 
|
| OXL-IMP-E0061 | Emtricitabine | C8H10FN3O3S | 247.24 | 143491-57-0 | 
|
| Catalogue Number | Name of the Impurity | Molecular Formula | Molecular Weight | CAS Number | Structure |
| Catalogue Number | Name of the Impurity | Molecular Formula | Molecular Weight | CAS Number | Structure |
|---|---|---|---|---|---|
| OXL-IMP-F0006 | Fosamprenavir Imp 4 | C19H32N2O3 | 336.48 | 143225-31-4 | 
|
| OXL-IMP-F0005 | Fosamprenavir Imp 3 | C19H32N2O3 | 336.48 | 1005324-40-2 | 
|
| OXL-IMP-F0004 | Fosamprenavir Imp 2 | C19H32N2O3 | 336.48 | 853904-81-1 | 
|
| OXL-IMP-F0003 | Fosamprenavir Imp 1 | C9H11NO6 | 229.19 | 160333-50-6 | 
|
| OXL-IMP-F0002 | Fosamprenavir-d4 | C25H32D4N3O9PS | 589.63 | 1133702-41-6 | 
|
| OXL-IMP-F0001 | Fosamprenavir | C25H36N3O9PS | 585.62 | 226700-79-4 | 
|
| Catalogue Number | Name of the Impurity | Molecular Formula | Molecular Weight | CAS Number | Structure |
| Catalogue Number | Name of the Impurity | Molecular Formula | Molecular Weight | CAS Number | Structure |
|---|---|---|---|---|---|
| OXL-IMP-G0009 | Gemcitabine Impurity 9 | C20H18F2O8S | 456.41 | 122111-11-9 | 
|
| OXL-IMP-G0008 | Gemcitabine Impurity 8 | C19H16F2O7 | 394.33 | 866473-33-8 | 
|
| OXL-IMP-G0007 | Gemcitabine Impurity 7 | C17H17F2N3O6 | 397.33 | 138685-83-3 | 
|
| OXL-IMP-G0006 | Gemcitabine Impurity 6 | C9H11F2N3O4 | 263.20 | 103882-85-5 | 
|
| OXL-IMP-G0005 | Gemcitabine Impurity 5 | C4H5N3O | 111.10 | 71-30-7 | 
|
| OXL-IMP-G0004 | Gemcitabine Impurity 4 | C9H10F2N2O5 | 264.19 | 294177-31-4 | 
|
| OXL-IMP-G0003 | Gemcitabine Impurity 3 | C8H11F2N15N2O4HCl | 302.64 | 122111-05-1 | 
|
| OXL-IMP-G0002 | Gemcitabine Impurity 2 |
C9H11F2N3O4HCl |
299.66 | 122111-05-1 | 
|
| OXL-IMP-G0001 | Gemcitabine Impurity 1 | C8H11F2NO4. HCl | 302.64 | 122111-03-9 | 
|
| Catalogue Number | Name of the Impurity | Molecular Formula | Molecular Weight | CAS Number | Structure |
| Catalogue Number | Name of the Impurity | Molecular Formula | Molecular Weight | CAS Number | Structure |
|---|---|---|---|---|---|
| OXL-IMP-I0008 | Ibrutinib Impurity 6 | C22H22N6O | 386.46 | 1022150-12-4 | 
|
| OXL-IMP-I0007 | Ibrutinib Impurity 5 | C17H13N5O | 303.33 | 330786-24-8 | 
|
| OXL-IMP-I0006 | Ibrutinib Impurity 4 | C10H19NO3 | 201.27 | 143900-44-1 | 
|
| OXL-IMP-I0005 | Ibrutinib Impurity 3 | C47H46N12O3 | 826.97 | 1987905-93-0 | 
|
| OXL-IMP-I0004 | Ibrutinib Impurity 2 | C25H25ClN6O2 | 476.97 | 1288338-96-4 | 
|
| OXL-IMP-I0003 | Ibrutinib Impurity 1 | C25H26N6O4 | 474.52 | 1654820-87-7 | 
|
| OXL-IMP-I0002 | (S)-Ibrutinib | C25H24N6O2 | 440.51 | 936563-97-2 | -Ibrutinib.jpg)
|
| OXL-IMP-I0001 | Ibrutinib | C25H24N6O2 | 440.51 | 936563-96-1 | 
|
| Catalogue Number | Name of the Impurity | Molecular Formula | Molecular Weight | CAS Number | Structure |
| Catalogue Number | Name of the Impurity | Molecular Formula | Molecular Weight | CAS Number | Structure |
|---|---|---|---|---|---|
| OXL-IMP-I0049 | Iloperidone Impurity 18 | C12H15BrO3 | 287.15 | 3245-49-6 | 
|
| OXL-IMP-I0048 | Iloperidone Impurity 17 | C12H13F2NO | 225.24 | 1388072-44-3 | 
|
| OXL-IMP-I0047 | Iloperidone Impurity 16 |
C12H14FNO. HCl |
243.71 | 64671-29-0; 98294-54-3 (free base) | 
|
| OXL-IMP-I0046 | Iloperidone Impurity 15 | C12H13FN2O. HCl | 256.71 | 84163-16-6 | 
|
| OXL-IMP-I0045 | Iloperidone Impurity 14 | C12H13F2NO. HCl | 261.7 | 1172297-96-9 | 
|
| OXL-IMP-I0044 | Iloperidone Impurity 13 | C10H13BrO3S | 293.18 | 81055-36-9 | 
|
| OXL-IMP-I0043 | Iloperidone Impurity 12 | C24H25FN4O2 | 420.49 | 531524-17-1 | 
|
| OXL-IMP-I0042 | Iloperidone Impurity 11 | C12H14F2N2O | 240.25 | 691007-07-5 | 
|
| OXL-IMP-I0041 | Iloperidone Impurity 10 | C24H27FN2O5 | 442.49 | 1375651-09-4 | 
|
| OXL-IMP-I0040 | Iloperidone Impurity 9 | C19H22O6S | 378.45 | 1309041-89-1 | 
|
| OXL-IMP-I0039 | Iloperidone Impurity 8 | C12H16O4 | 224.26 | 207298-39-3 | 
|
| OXL-IMP-I0038 | Iloperidone Impurity 7 | C23H26FN2O4D3 | 432.52 | 133454-55-4 (non-labelled) | 
|
| OXL-IMP-I0037 | Iloperidone Impurity 6 | C36H39FN4O5 | 626.73 | 1375651-23-2 | 
|
| OXL-IMP-I0036 | Iloperidone Impurity 5 |
C23H25FN2O5 |
428.46 | 475110-48-6 | 
|
| OXL-IMP-I0035 | Iloperidone Impurity 4 | C24H29FN2O4 | 428.51 | 133454-55-4 | 
|
| OXL-IMP-I0034 | Iloperidone Impurity 3 | C24H27FN2O4 | 426.49 | 133454-47-4 | 
|
| OXL-IMP-I0033 | Iloperidone Impurity 2 | C24H21FN2O4D6 | 432.52 | 133454-47-4 | 
|
| OXL-IMP-I0032 | Iloperidone Impurity 1 | C23H24D3FN2O4 | 430.50 | 133454-47-4 (non-labelled) | 
|
| OXL-IMP-I0031 | Iloperidone | C24H27FN2O4 | 426.49 | 133454-47-4 | 
|
| Catalogue Number | Name of the Impurity | Molecular Formula | Molecular Weight | CAS Number | Structure |
| Catalogue Number | Name of the Impurity | Molecular Formula | Molecular Weight | CAS Number | Structure |
|---|---|---|---|---|---|
| OXL-IMP-I0087 | Imatinib Impurity 27 | C8H5Br2N | 274.94 | 67013-55-2 | 
|
| OXL-IMP-I0086 | Imatinib Impurity 26 | C8H5Cl2N | 186.04 | 74231-65-5 | 
|
| OXL-IMP-I0085 | Imatinib Impurity 25 | C20H22N2O4 | 354.41 | 1802325-93-4 | 
|
| OXL-IMP-I0084 | Imatinib Impurity 24 | C7H7NO | 121.14 | 350-03-8 | 
|
| OXL-IMP-I0083 | Imatinib Impurity 23 | C42H47N9O2 | 709.90 | 1356565-46-2 | 
|
| OXL-IMP-I0082 | Imatinib Impurity 22 | C8H12N4 | 164.21 | 581076-64-4 | 
|
| OXL-IMP-I0081 | Imatinib Impurity 21 | C16H15N5 | 277.33 | 112696-91-0 | 
|
| OXL-IMP-I0080 | Imatinib Impurity 20 | C30H33N7O | 507.64 | 942514-62-7 | 
|
| OXL-IMP-I0079 | Imatinib Impurity 19 | C29H31N7O | 493.62 | 1026753-54-7 | 
|
| OXL-IMP-I0078 | Imatinib Impurity 18 | C24H21N5O | 395.47 | 152459-96-6 | 
|
| OXL-IMP-I0077 | Imatinib Impurity 17 | C21H28N6O | 380.50 | 581076-65-5 | 
|
| OXL-IMP-I0076 | Imatinib Impurity 16 | C13H18N2O2 | 234.30 | 106261-48-7 | 
|
| OXL-IMP-I0075 | Imatinib Impurity 15 | C10H12N2O | 176.22 | 123367-26-0 | 
|
| OXL-IMP-I0074 | Imatinib Impurity 14 | C16H13N5O2 | 307.31 | 152460-09-8 | 
|
| OXL-IMP-I0073 | Imatinib Impurity 13 | C16H15N5 | 277.33 | 152460-10-1 | 
|
| OXL-IMP-I0072 | Imatinib Impurity 12 | C24H20ClN5O | 429.91 | 404844-11-7 | 
|
| OXL-IMP-I0071 | Imatinib Impurity 11 | C29H31N7O | 493.62 | 1246819-59-9 | 
|
| OXL-IMP-I0070 | Imatinib Impurity 10 | C52H48N12O2 | 873.04 | 1365802-18-1 | 
|
| OXL-IMP-I0069 | Imatinib Impurity 9 | C29H31N7O2 | 509.62 | 938082-57-6 | 
|
| OXL-IMP-I0068 | Imatinib Impurity 8 | C29H31N7O3 | 525.61 | 571186-93-1 | 
|
| OXL-IMP-I0067 | Imatinib Impurity 7 |
C29H31N7O.CH4O3S |
589.73 | 220127-57-1 | 
|
| OXL-IMP-I0066 | Imatinib Impurity 6 | C29H31N7O2 | 509.61 | 571186-92-0 | 
|
| OXL-IMP-I0065 | Imatinib Impurity 5 | C29H31N7O2 | 509.61 | 571186-91-9 | 
|
| OXL-IMP-I0064 | Imatinib Impurity 4 | C28H21N7OD8 | 487.64 | 1185103-28-9 | 
|
| OXL-IMP-I0063 | Imatinib Impurity 3 | C28H29N7O | 479.59 | 404844-02-6 | 
|
| OXL-IMP-I0062 | Imatinib Impurity 2 | C29H23D8N7O | 501.66 | 1092942-82-9 | 
|
| OXL-IMP-I0061 | Imatinib Impurity 1 | C29H31N7O | 493.62 | 152459-95-5 | 
|
| Catalogue Number | Name of the Impurity | Molecular Formula | Molecular Weight | CAS Number | Structure |
| Catalogue Number | Name of the Impurity | Molecular Formula | Molecular Weight | CAS Number | Structure |
|---|---|---|---|---|---|
| OXL-IMP-L0021 | Acetylsalicylic Acid (Aspirin) | C9H8O4 | 180.16 | 50-78-2 | .jpg)
|
| OXL-IMP-L0020 | Acetylsalicylic Acid Impurity A-d4 | C7H2D4O3 | 142.15 | 152404-47-2 | 
|
| OXL-IMP-L0018 | Acetylsalicylic Acid Impurity 5 | C11H10O5 | 222.20 | 18698-59-4 | 
|
| OXL-IMP-L0016 | Salicylglycine | C9H9NO4 | 195.17 | 487-54-7 | 
|
| OXL-IMP-L0015 | Gentisuric Acid | C9H9NO5 | 211.17 | 25351-24-0 | 
|
| OXL-IMP-L0012 | Acetylsalicylic Acid Impurity 3 | C8H7NO5 | 197.15 | 15540-79-1 | 
|
| OXL-IMP-L0011 | Acetylsalicylic Acid Impurity 2 | C12H10N2O3 | 230.22 | 318515-20-7 | 
|
| OXL-IMP-L0010 | Acetylsalicylsalicylsalicylic Acid | C23H16O8 | 420.37 | 85531-16-4 | 
|
| OXL-IMP-L0009 | Acetylsalicylic Acid EP Impurity E |
C14H10O5 |
258.23 | 552-94-3 | 
|
| OXL-IMP-L0008 | Acetylsalicylic Acid EP Impurity B |
C14H10O5 |
258.23 | 552-94-3 | 
|
| OXL-IMP-L0007 | Acetylsalicylic Acid-d4 (Aspirin-d4) | C9H4D4O4 | 184.18 | 97781-16-3 | .jpg)
|
| OXL-IMP-L0005 | Acetylsalicylic Acid EP Impurity F | C18H14O7 | 342.30 | 1466-82-6 | 
|
| OXL-IMP-L0004 | Acetylsalicylic Acid EP Impurity D | C16H12O6 | 300.27 | 530-75-6 | 
|
| OXL-IMP-L0003 | Acetylsalicylic Acid EP Impurity C | C7H6O3 | 138.12 | 69-72-7 | 
|
| OXL-IMP-L0002 | Acetylsalicylic Acid Impurity A | C7H6O3 | 138.12 | 99-96-7 | 
|
| OXL-IMP-L0001 | Acetylsalicylic Acid-d3 (Aspirin-d3) | C9H5D3O4 | 183.18 | 50-78-2 | .jpg)
|
| Catalogue Number | Name of the Impurity | Molecular Formula | Molecular Weight | CAS Number | Structure |
| Catalogue Number | Name of the Impurity | Molecular Formula | Molecular Weight | CAS Number | Structure |
|---|---|---|---|---|---|
| OXL-IMP-L0047 | Linagliptin Impurity 16 | C6H5BrN4O2 | 245.04 | 93703-24-3 | 
|
| OXL-IMP-L0046 | Linagliptin Impurity 15 | C10H9ClN2 | 192.65 | 109113-72-6 | 
|
| OXL-IMP-L0045 | Linagliptin Impurity 14 | C10H10N2O | 174.20 | 13535-91-6 | 
|
| OXL-IMP-L0044 | Linagliptin Impurity 13 | C54H62N16O4 | 999.20 | 1643364-41-3 | 
|
| OXL-IMP-L0043 | Linagliptin Impurity 12 | C20H17BrN6O2 | 453.30 | 853029-57-9 | 
|
| OXL-IMP-L0042 | Linagliptin Impurity 11 | C25H28N8O2 | 472.55 | 1446263-38-2 | 
|
| OXL-IMP-L0041 | Linagliptin Impurity 10 | C20H28N6O4 | 416.48 | 666816-91-7 | 
|
| OXL-IMP-L0040 | Linagliptin Impurity 9 | C22H23N7O2 | 417.47 | 1646355-34-1 | 
|
| OXL-IMP-L0039 | Linagliptin Impurity 8 | C30H36N8O4 | 572.67 | 668273-75-4 | 
|
| OXL-IMP-L0038 | Linagliptin Impurity 7 | C10H9BrN4O2 | 297.11 | 666816-98-4 | 
|
| OXL-IMP-L0037 | Linagliptin Impurity 6 | C22H23N7O2 | 417.47 | 1646355-34-1 | 
|
| OXL-IMP-L0036 | Linagliptin Impurity 5 | C27H30N8O3 | 514.59 | 1803079-49-3 | 
|
| OXL-IMP-L0035 | Linagliptin Impurity 4 | C25H28N8O2 | 472.55 | 668270-11-9 | 
|
| OXL-IMP-L0033 | Linagliptin Impurity 2 | C25H29BrN8O2 | 553.47 | 1638744-06-5 | 
|
| OXL-IMP-L0032 | Linagliptin Impurity 1 | C50H56N16O4 | 945.11 | 1418133-47-7 | 
|
| OXL-IMP-L0031 | Linagliptin | C25H28N8O2 | 472.55 | 668270-12-0 | 
|
| Catalogue Number | Name of the Impurity | Molecular Formula | Molecular Weight | CAS Number | Structure |
| Catalogue Number | Name of the Impurity | Molecular Formula | Molecular Weight | CAS Number | Structure |
|---|---|---|---|---|---|
| OXL-IMP-L0064 | Lopinavir Impurity 2 | C38H50N4O5 | 642.85 | 1132765-59-3 | 
|
| OXL-IMP-L0063 | Lopinavir Impurity 1 | C37H48N4O6 | 644.81 | 357275-54-8 | 
|
| OXL-IMP-L0062 | Lopinavir EP Impurity S | C47H58N4O7 | 791.00 | 943250-65-5 | 
|
| OXL-IMP-L0061 | Lopinavir | C37H48N4O5 | 628.82 | 192725-17-0 | 
|
| Catalogue Number | Name of the Impurity | Molecular Formula | Molecular Weight | CAS Number | Structure |
| Catalogue Number | Name of the Impurity | Molecular Formula | Molecular Weight | CAS Number | Structure |
|---|---|---|---|---|---|
| OXL-IMP-M0009 | Mesna Impurity 8 | C4H10O4S | 154.18 | 90663-51-7 | 
|
| OXL-IMP-M0008 | Mesna Impurity 7 | C5H8O7S4. 2Na | 354.35 | 1110574-95-2 | 
|
| OXL-IMP-M0007 | Mesna Impurity 6 | C4H9BrO3S | 217.08 | 41239-91-3 | 
|
| OXL-IMP-M0006 | Mesna Impurity 5 | C3H7BrO3S | 203.06 | 41239-91-2 | 
|
| OXL-IMP-M0005 | Mesna Impurity 4 | C3H8O3S2 | 156.22 | 1709792-04-0 | 
|
| OXL-IMP-M0004 | Mesna Impurity 3 | C4H10O6S4 | 282.38 | 45127-11-5 | 
|
| OXL-IMP-M0003 | Mesna Impurity 2 | C4H8O4S2 | 184.23 | 69536-71-6 | 
|
| OXL-IMP-M0002 | Mesna Impurity 1 | C3H8N2O3S2 | 184.24 | 25985-57-3 | 
|
| OXL-IMP-M0001 | Mesna | C2H5O3S2. Na | 164.17 | 19767-45-4 | 
|
| Catalogue Number | Name of the Impurity | Molecular Formula | Molecular Weight | CAS Number | Structure |
| Catalogue Number | Name of the Impurity | Molecular Formula | Molecular Weight | CAS Number | Structure |
|---|---|---|---|---|---|
| OXL-IMP-O0035 | Olmesartan Imp 34 | C33H25BrN4 | 557.50 | 133051-88-4 | 
|
| OXL-IMP-M0041 | Methotrexate Imp 11 | C20H21N7O6 | 455.43 | 7444-29-3 | 
|
| OXL-IMP-M0040 | Methotrexate Imp 10 | C15H18N6O3 | 330.35 | 4349-41-1 | 
|
| OXL-IMP-M0039 | Methotrexate Imp 9 | C15H16N6O4 | 344.33 | 4349-43-3 | 
|
| OXL-IMP-M0038 | Methotrexate Imp 8 | C12H14N2O5 | 266.26 | 5959-18-2 | 
|
| OXL-IMP-M0037 | Methotrexate Imp 7 | C20H23N7O7 | 473.45 | 68538-85-2 | 
|
| OXL-IMP-M0036 | Methotrexate Imp 6 | C19H21N7O6 | 443.42 | 4033-27-6 | 
|
| OXL-IMP-M0035 | Methotrexate Imp 5 | C20H21N7O7 | 471.43 | 28459-40-7 | 
|
| OXL-IMP-M0034 | Methotrexate Imp 4 | C15H16N6O4 | 344.33 | 944737-05-7 | |
| OXL-IMP-M0033 | Methotrexate Imp 3 | C21H23N7O8 | 501.46 | 98814-60-9 | 
|
| OXL-IMP-M0032 | Methotrexate Imp 2 | C12H14N2O5 | 266.26 | 4271-30-1 | 
|
| OXL-IMP-M0031 | Methotrexate Imp 1 | C20H21N7O7. Ca | 511.51 | 1492-18-8 | 
|
| Catalogue Number | Name of the Impurity | Molecular Formula | Molecular Weight | CAS Number | Structure |
| Catalogue Number | Name of the Impurity | Molecular Formula | Molecular Weight | CAS Number | Structure |
|---|---|---|---|---|---|
| OXL-IMP-O0041 | Olmesartan Imp 40 | C14H9Br2N | 351.04 | 209911-63-7 | 
|
| OXL-IMP-O0040 | Olmesartan Imp 39 | C33H25ClN4 | 513.04 | 885216-74-0 | 
|
| OXL-IMP-O0039 | Olmesartan Imp 38 | C44H40N6O3 | 700.84 | 2101308-73-8 | 
|
| OXL-IMP-O0038 | Olmesartan Imp 37 | C43H38N6O2 | 670.82 | 1048948-15-7 | 
|
| OXL-IMP-O0037 | Olmesartan Imp 36 | C33H26N4O | 494.60 | 154709-18-9 | 
|
| OXL-IMP-O0036 | Olmesartan Imp 35 | C10H16N2O3 | 212.25 | 144690-04-0 | 
|
| OXL-IMP-O0034 | Olmesartan Imp 33 | C5H6O3 | 114.10 | 37830-90-3 | 
|
| OXL-IMP-O0033 | Olmesartan Imp 32 | C19H15Cl | 278.78 | 76-83-5 | 
|
| OXL-IMP-O0032 | Olmesartan Imp 31 | C14H11N | 193.25 | 114772-53-1 | 
|
| OXL-IMP-O0031 | Olmesartan Imp 30 | C10H14N2O2 | 194.23 | 849206-42-4 | 
|
| OXL-IMP-O0030 | Olmesartan Imp 29 | C12H18N2O2 | 222.29 | 157356-73-5 | 
|
| OXL-IMP-O0029 | Olmesartan Imp 28 | C12H18N2O4 | 254.29 | 144689-94-1 | 
|
| OXL-IMP-O0028 | Olmesartan Imp 27 | C8H10N2O4 | 198.18 | 58954-23-7 | 
|
| OXL-IMP-O0027 | Olmesartan Imp 26 | C5H6Cl2O3 | 185.00 | 116857-04-6 | 
|
| OXL-IMP-O0026 | Olmesartan Imp 25 | C5H4Cl2O3 | 182.98 | 1443544-27-1 | 
|
| OXL-IMP-O0025 | Olmesartan Imp 24 | C44H40N6O3 | 700.84 | 2101308-74-9 | 
|
| OXL-IMP-O0024 | Olmesartan Imp 23 | C11H16N2O3 | 224.26 | 144690-07-3 | 
|
| OXL-IMP-O0023 | Olmesartan Imp 22 | C5H5ClO3 | 148.55 | 95579-71-8 | 
|
| OXL-IMP-O0022 | Olmesartan Imp 21 | C13H22N2O3 | 254.33 | 1092980-84-1 | 
|
| OXL-IMP-O0021 | Olmesartan Imp 20 | C34H34N6O9 | 670.68 | 1392475-91-0 | 
|
| OXL-IMP-O0020 | Olmesartan Imp 19 | C43H39N6O3 Li | 694.77 | 761404-85-7 | 
|
| OXL-IMP-O0019 | Olmesartan Imp 18 | C25H28N6O2 | 444.54 | 1227626-45-0 | 
|
| OXL-IMP-O0018 | Olmesartan Imp 17 | C20H18O | 274.37 | 596-31-6 | 
|
| OXL-IMP-O0017 | Olmesartan Imp 16 | C48H44N6O6 | 800.92 | 1020157-01-0 | 
|
| OXL-IMP-O0016 | Olmesartan Imp 15 | C5H5ClO3 | 148.54 | 80841-78-7 | 
|
| OXL-IMP-O0015 | Olmesartan Imp 14 | C33H25BrN4 | 557.50 | 124750-51-2 | 
|
| OXL-IMP-O0014 | Olmesartan Imp 13 | C26H30N6O3 | 474.57 | 144689-23-6 | 
|
| OXL-IMP-O0013 | Olmesartan Imp 12 | C45H44N6O3 | 716.89 | 144690-33-5 | 
|
| OXL-IMP-O0012 | Olmesartan Imp 11 | C24H24N6O2 | 428.50 | 849206-43-5 | 
|
| OXL-IMP-O0011 | Olmesartan Imp 10 | C29H28N6O5 | 540.58 | 879562-26-2 | 
|
| OXL-IMP-O0010 | Olmesartan Impurity 9 | C30H32N6O6 | 572.63 | 896419-17-3 | 
|
| OXL-IMP-O0009 | Olmesartan Impurity 8 | C48H50N12O5 | 875.01 | 1040250-19-8 | 
|
| OXL-IMP-O0008 | Olmesartan Impurity 7 | C12H20N2O3 | 240.30 | 144689-93-0 | 
|
| OXL-IMP-O0007 | Olmesartan Impurity 6 | C48H44N6O6 | 800.92 | 144690-92-6 | 
|
| OXL-IMP-O0006 | Olmesartan Impurity 5 | C30H32N6O6 | 572.62 | 1378863-74-1 | 
|
| OXL-IMP-O0005 | Olmesartan Impurity 4 | C25H28N6O3 | 460.54 | 1347262-29-6 | 
|
| OXL-IMP-O0004 | Olmesartan Impurity 3 | C24H24N6O | 428.50 | 172875-98-8 | 
|
| OXL-IMP-O0003 | Olmesartan Impurity 2 | C24H22N6O3D4 | 450.54 | 1420880-41-6 | 
|
| OXL-IMP-O0002 | Olmesartan Impurity 1 | C24H26N6O3 | 446.51 | 144689-24-7 | 
|
| OXL-IMP-O0001 | Olmesartan Medoxomil | C29H30N6O6 | 558.60 | 144689-63-4 | 
|
| Catalogue Number | Name of the Impurity | Molecular Formula | Molecular Weight | CAS Number | Structure |
| Catalogue Number | Name of the Impurity | Molecular Formula | Molecular Weight | CAS Number | Structure |
|---|---|---|---|---|---|
| OXL-IMP-O0082 | Oseltamivir Imp 21 | C24H42N2O3 | 406.61 | 651324-06-0 | 
|
| OXL-IMP-O0081 | Oseltamivir Imp 20 | C9H12O4 | 184.19 | 241465-24-7 | 
|
| OXL-IMP-O0080 | Oseltamivir Imp 19 | C15H26O7S | 350.43 | 204254-94-4 | 
|
| OXL-IMP-O0079 | Oseltamivir Imp 18 | C15H26O7S | 350.43 | 204254-92-2 | 
|
| OXL-IMP-O0078 | Oseltamivir Imp 17 | C11H18N2O4 | 242.28 | 903907-74-4 | 
|
| OXL-IMP-O0077 | Oseltamivir Imp 16 | C16H28N2O4. H3O4P | 410.4 | 1035895-89-6 | 
|
| OXL-IMP-O0076 | Oseltamivir Imp 15 | C14H22O4 | 254.33 | 1234858-94-6 | 
|
| OXL-IMP-O0075 | Oseltamivir Imp 14 | C14H22O4 | 254.33 | 347378-74-9 | 
|
| OXL-IMP-O0074 | Oseltamivir Imp 13 | C14H22O4 | 254.33 | 1266663-89-1 | 
|
| OXL-IMP-O0073 | Oseltamivir Imp 12 | C12H18O5 | 242.27 | 136994-78-0 | 
|
| OXL-IMP-O0072 | Oseltamivir Imp 11 | C18H15OP | 278.29 | 791-28-6 | 
|
| OXL-IMP-O0071 | Oseltamivir Imp 10 | C15H26N2O4. HCl | 334.84 | 208720-78-9 | 
|
| OXL-IMP-O0070 | Oseltamivir Imp 9 | C14H24N2O4. HCl | 320.82 | 1364932-19-3 (free base) | 
|
| OXL-IMP-O0069 | Oseltamivir Imp 8 | C11H13NO4 | 223.23 | 1346604-18-9 | 
|
| OXL-IMP-O0068 | Oseltamivir Imp 7 | C15H26N2O4 | 298.38 | 1052063-37-2 | 
|
| OXL-IMP-O0067 | Oseltamivir Imp 6 | C16H28N2O4 | 312.41 | 956267-10-0 | 
|
| OXL-IMP-O0066 | Oseltamivir Imp 5 | C14H21N2O4D3. HCl | 323.84 | 1415963-60-8 (non-labelled) | 
|
| OXL-IMP-O0065 | Oseltamivir Imp 4 | C16H25D3N2O4 | 315.43 | 1093851-61-6 | 
|
| OXL-IMP-O0064 | Oseltamivir Imp 3 | C14H24N2O4. HCl | 320.82 | 1415963-60-8; 187227-45-8 (free base) | 
|
| OXL-IMP-O0063 | Oseltamivir Imp 2 | C16H23N2O4D5.HCl | 353.9 | 204255-09-4 | 
|
| OXL-IMP-O0062 | Oseltamivir Imp 1 | C16H28N2O4. HCl | 348.87 | 204255-09-4 | 
|
| OXL-IMP-O0061 | Oseltamivir Phosphate | C16H28N2O4.H3PO4 | 411.69 | 204255-11-8 | 
|
| Catalogue Number | Name of the Impurity | Molecular Formula | Molecular Weight | CAS Number | Structure |
| Catalogue Number | Name of the Impurity | Molecular Formula | Molecular Weight | CAS Number | Structure |
|---|---|---|---|---|---|
| OXL-IMP-O0092 | Oxaliplatin Imp 1 | C12H26N4O2Pt2 2NO3 | 772.57 | 82398-34-3 | 
|
| OXL-IMP-O0091 | Oxaliplatin | C8H14N2O4Pt | 397.29 | 61825-94-3 | 
|
| Catalogue Number | Name of the Impurity | Molecular Formula | Molecular Weight | CAS Number | Structure |
| Catalogue Number | Name of the Impurity | Molecular Formula | Molecular Weight | CAS Number | Structure |
|---|---|---|---|---|---|
| OXL-IMP-P0020 | Paliperidone Imp 19 | C11H16N2O3 | 224.26 | 1160915-55-8 | 
|
| OXL-IMP-P0019 | Paliperidone Imp 18 | C13H17ClN2O3 | 284.74 | 1117803-76-5 | 
|
| OXL-IMP-P0018 | Paliperidone Imp 17 | C11H14N2O2 | 206.25 | 1008796-23-3 | 
|
| OXL-IMP-P0017 | Paliperidone Imp 16 | C39H26FN4O4D31 | 696.10 | 199739-10-1 | 
|
| OXL-IMP-P0016 | Paliperidone Imp 15 | C23H24N4O3D4 | 412.53 | 1380413-60-4 | 
|
| OXL-IMP-P0015 | Paliperidone Imp 14 | C27H45ClN2O3 | 481.12 | 1415488-05-9 | 
|
| OXL-IMP-P0014 | Paliperidone Imp 13 | C11H13ClN2O2 | 240.69 | 1138463-56-5 | 
|
| OXL-IMP-P0013 | Paliperidone Imp 12 | C23H28FN3O4 | 429.49 | 152542-03-5 | 
|
| OXL-IMP-P0012 | Paliperidone Imp 11 | C11H15ClN2O | 226.71 | 95742-20-4 | 
|
| OXL-IMP-P0011 | Paliperidone Imp 10 | C11H16N2O2 | 208.26 | 849903-79-3 | 
|
| OXL-IMP-P0010 | Paliperidone Imp 9 | C11H11ClN2O2 | 238.68 | 260273-82-3 | 
|
| OXL-IMP-P0009 | Paliperidone Imp 8 | C12H13FN2O. HCl | 256.71 | 84163-13-3 | 
|
| OXL-IMP-P0008 | Paliperidone Imp 7 | C11H15ClN2O2 | 242.71 | 130049-82-0 | 
|
| OXL-IMP-P0007 | Paliperidone Imp 6 | C23H28F2N4O3 | 446.50 | 1388021-47-3 | 
|
| OXL-IMP-P0006 | Paliperidone Imp 5 | C23H28F2N4O3 | 446.50 | 1388021-46-2 | 
|
| OXL-IMP-P0005 | Paliperidone Imp 4 | C23H28N4O3 | 408.50 | 1380413-60-4 | 
|
| OXL-IMP-P0004 | Paliperidone Imp 3 | C23H25FN4O3 | 424.48 | 1189516-65-1 | 
|
| OXL-IMP-P0003 | Paliperidone Imp 2 | C23H27FN4O3 | 426.50 | 1346598-34-2 | 
|
| OXL-IMP-P0002 | Paliperidone Imp 1 | C23H23FN4O3 | 422.46 | 766485-15-8 | 
|
| OXL-IMP-P0001 | Paliperidone Palmitate | C39H57FN4O4 | 664.91 | 199739-10-1 | 
|
| Catalogue Number | Name of the Impurity | Molecular Formula | Molecular Weight | CAS Number | Structure |
| Catalogue Number | Name of the Impurity | Molecular Formula | Molecular Weight | CAS Number | Structure |
|---|---|---|---|---|---|
| OXL-IMP-R0005 | Rilpivirine Impurity 5 | C18H12N6 | 312.34 | 1629023-90-0 | 
|
| OXL-IMP-R0004 | Rilpivirine Impurity 4 | C22H18N6 | 366.43 | 500287-72-9 | 
|
| OXL-IMP-R0003 | Rilpivirine Impurity 3 | C22H18N6. HCl | 402.89 | 500287-94-5 | 
|
| OXL-IMP-R0002 | Rilpivirine Impurity 2 | C28H26N6O6 | 542.56 | 143779-52-0 | 
|
| OXL-IMP-R0001 | Rilpivirine Impurity 1 | C22H12N6D6. HCl | 372.47 36.46 | 700361-47-3 | 
|
| Catalogue Number | Name of the Impurity | Molecular Formula | Molecular Weight | CAS Number | Structure |
| Catalogue Number | Name of the Impurity | Molecular Formula | Molecular Weight | CAS Number | Structure |
|---|---|---|---|---|---|
| OXL-IMP-R0048 | Rizatriptan Imp 17 | C36H49N11 | 635.87 | 1135479-41-2 | 
|
| OXL-IMP-R0047 | Rizatriptan Imp 16 | C13H14N4O | 242.28 | 160194-39-8 | 
|
| OXL-IMP-R0046 | Rizatriptan Imp 15 | C13H12N4O2 | 256.27 | 177270-91-6 | 
|
| OXL-IMP-R0045 | Rizatriptan Imp 14 | C14H14N5D3C7H6O2 | 381.45 | 144034-84-4 | 
|
| OXL-IMP-R0044 | Rizatriptan Imp 13 | C14H14N5D3. C7H6O2 | 380.46 | 144034-84-4 | 
|
| OXL-IMP-R0043 | Rizatriptan Imp 12 | C13H13ClN4 | 260.73 | 1000673-59-5 | 
|
| OXL-IMP-R0042 | Rizatriptan Imp 11 | C16H22N5. Cl | 319.84 | 1030849-63-8 | 
|
| OXL-IMP-R0041 | Rizatriptan Imp 10 | C28H35N7.C7H6O2 | 591.76 | 1016900-25-6 | 
|
| OXL-IMP-R0040 | Rizatriptan Impurity 9 | C28H35N7 | 469.64 | 887001-08-3 | 
|
| OXL-IMP-R0039 | Rizatriptan Impurity 8 | C9H11N5. 2 HCl | 262.14 | 212248-62-9 | 
|
| OXL-IMP-R0038 | Rizatriptan Impurity 7 | C36H49N11 | 635.87 | 1135479-44-5 | 
|
| OXL-IMP-R0037 | Rizatriptan Impurity 6 | C15H19N5 | 269.35 | 208941-96-2 | 
|
| OXL-IMP-R0036 | Rizatriptan Impurity 5 | C13H15N5. C2H2O4 | 331.34 | 144035-23-4 | 
|
| OXL-IMP-R0035 | Rizatriptan Impurity 4 | C14H17N5. C7H6O2 | 377.45 | 144034-84-4 | 
|
| OXL-IMP-R0034 | Rizatriptan Impurity 3 | C14H17N5 | 255.33 | 144034-84-4 | 
|
| OXL-IMP-R0033 | Rizatriptan Impurity 2 | C15H19N5O | 285.35 | 260435-42-5 | 
|
| OXL-IMP-R0032 | Rizatriptan Impurity 1 | C15H13N5D6. C7H6O2 | 397.51 | 1216984-85-8 | 
|
| OXL-IMP-R0031 | Rizatriptan Benzoate | C15H19N5. C7H6O2 | 391.47 | 145202-66-0 | 
|
| Catalogue Number | Name of the Impurity | Molecular Formula | Molecular Weight | CAS Number | Structure |
| Catalogue Number | Name of the Impurity | Molecular Formula | Molecular Weight | CAS Number | Structure |
|---|---|---|---|---|---|
| OXL-IMP-S0018 | Saxagliptin Imp 17 | C17H25NO5 | 323.39 | 2173146-31-9 | 
|
| OXL-IMP-S0017 | Saxagliptin Imp 16 | C6H10N2O. C2HF3O2 | 240.18 | 700376-58-5 | 
|
| OXL-IMP-S0016 | Saxagliptin Imp 15 | C6H10N2O. C2HF3O2 | 240.18 | 1133811-50-3 | 
|
| OXL-IMP-S0015 | Saxagliptin Imp 14 |
C11H16O3 |
196.25 | 42711-75-1 | 
|
| OXL-IMP-S0014 | Saxagliptin Imp 13 |
C17H27NO5 |
325.41 | 1334321-39-9 | 
|
| OXL-IMP-S0013 | Saxagliptin Imp 12 |
C17H27NO4 |
309.41 | 361441-97-6 | 
|
| OXL-IMP-S0012 | Saxagliptin Imp 11 |
C18H25N3O2 |
315.42 | 1564265-94-6 | 
|
| OXL-IMP-S0011 | Saxagliptin Imp 10 |
C17H23N3O3D2.
HCl |
334.42 36.46 | 841302-24-7 (free base, non-labelled) | 
|
| OXL-IMP-S0010 | Saxagliptin Impurity 9 | C18H23N3O2. HCl | 349.86 | 2173146-35-3 | 
|
| OXL-IMP-S0009 | Saxagliptin Impurity 8 | C18H27N3O3. HCl | 333.43 36.46 | 1496712-39-0 (free base) | 
|
| OXL-IMP-S0008 | Saxagliptin Impurity 7 | C11H17NO4 | 227.26 | 197142-36-2 | 
|
| OXL-IMP-S0007 | Saxagliptin Impurity 6 | C10H16N2O3 | 212.25 | 709031-38-9 | 
|
| OXL-IMP-S0006 | Saxagliptin Impurity 5 | C18H24N2O3 | 316.40 | 1350800-77-9 | 
|
| OXL-IMP-S0005 | Saxagliptin Impurity 4 | C17H27NO6 | 341.41 | 681282-72-4 | 
|
| OXL-IMP-S0004 | Saxagliptin Impurity 3 | C18H25N3O2 | 315.42 | 1350800-76-8 | 
|
| OXL-IMP-S0003 | Saxagliptin Impurity 2 | C18H25N3O2 | 315.42 | 1564265-93-5 | 
|
| OXL-IMP-S0002 | Saxagliptin Impurity 1 | C17H23N3O2D2. HCl | 354.88 | 361442-04-8 (non-labelled) | 
|
| OXL-IMP-S0001 | Saxagliptin | C18H25N3O2 | 315.42 | 945667-22-1 | 
|
| Catalogue Number | Name of the Impurity | Molecular Formula | Molecular Weight | CAS Number | Structure |
| Catalogue Number | Name of the Impurity | Molecular Formula | Molecular Weight | CAS Number | Structure |
|---|---|---|---|---|---|
| OXL-IMP-T0011 | Ticagrelor Impurity 10 | C23H28F2N6O4S | 522.57 | 1788033-05-5 | 
|
| OXL-IMP-T0010 | Ticagrelor Impurity 9 | C26H32F2N6O4S | 562.64 | 274693-26-4 | 
|
| OXL-IMP-T0009 | Ticagrelor Impurity 8 | C14H21N5O5S | 371.41 | 1445580-43-7 | 
|
| OXL-IMP-T0008 | Ticagrelor Impurity 7 | C10H19NO4. C2H2O4 | 307.31 | 1816939-47-5 | 
|
| OXL-IMP-T0007 | Ticagrelor Impurity 6 | C17H27ClN4O4S | 418.95 | 376608-74-1 | 
|
| OXL-IMP-T0006 | Ticagrelor Impurity 5 | C20H22F2N6O5 | 464.43 | 1644461-81-3 | 
|
| OXL-IMP-T0005 | Ticagrelor Impurity 4 | C9H9F2N. HCl | 205.64 | 1414348-35-8 | 
|
| OXL-IMP-T0004 | Ticagrelor Impurity 3 | C23H29FN6O4S | 504.58 | 1643378-47-5 | 
|
| OXL-IMP-T0003 | Ticagrelor Impurity 2 | C23H28F2N6O6S | 554.58 | 274693-39-9 | 
|
| OXL-IMP-T0002 | Ticagrelor Impurity 1 | C25H30F2N6O5S | 564.62 | 1616703-93-5 | 
|
| OXL-IMP-T0001 | Ticagrelor | C23H28F2N6O4S | 522.57 | 274693-27-5 | 
|
| Catalogue Number | Name of the Impurity | Molecular Formula | Molecular Weight | CAS Number | Structure |
| Catalogue Number | Name of the Impurity | Molecular Formula | Molecular Weight | CAS Number | Structure |
|---|---|---|---|---|---|
| OXL-IMP-V0019 | Vildagliptin Imp 18 | C7H10N2O2 | 154.17 | 1563006-28-9 | 
|
| OXL-IMP-V0018 | Vildagliptin Imp 17 | C10H16O2 | 168.24 | 5001-18-3 | 
|
| OXL-IMP-V0017 | Vildagliptin Imp 16 | C5H8N2 | 96.13 | 204387-53-1 | 
|
| OXL-IMP-V0016 | Vildagliptin Imp 15 | C7H10ClNO3 | 191.61 | 23500-10-9 | 
|
| OXL-IMP-V0015 | Vildagliptin Imp 14 | C23H32N3O8. Na | 501.52 | 1147403-03-9 (free acid) | 
|
| OXL-IMP-V0014 | Vildagliptin Imp 13 | C17H27N3O3 | 321.42 | 565453-39-6 | 
|
| OXL-IMP-V0013 | Vildagliptin Imp 12 | C10H17NO | 167.25 | 702-82-9 | 
|
| OXL-IMP-V0012 | Vildagliptin Imp 11 | C7H9ClN2O | 172.61 | 207557-35-5 | 
|
| OXL-IMP-V0011 | Vildagliptin Imp 10 | C7H9ClN2O | 172.61 | 565452-98-4 | 
|
| OXL-IMP-V0010 | Vildagliptin Imp 9 | C10H14N2O2 | 194.23 | 6708-06-1 | 
|
| OXL-IMP-V0009 | Vildagliptin Imp 8 | C17H23N3O2 | 301.39 | 1846606-31-2 | 
|
| OXL-IMP-V0008 | Vildagliptin Imp 7 | C12H19NO3 | 225.29 | 1032564-18-3 | 
|
| OXL-IMP-V0007 | Vildagliptin Imp 6 | C17H25N3O2 | 303.41 | 1036959-27-9 | 
|
| OXL-IMP-V0006 | Vildagliptin Imp 5 | C24H33N5O3 | 439.56 | 1036959-23-5 | 
|
| OXL-IMP-V0005 | Vildagliptin Imp 4 | C17H24N2O3 | 304.39 | 1789703-36-1 | 
|
| OXL-IMP-V0004 | Vildagliptin Imp 3 | C17H25N3O2 | 303.41 | 1789703-37-2 | 
|
| OXL-IMP-V0003 | Vildagliptin Imp 2 | C17H18D7N3O2 | 310.45 | 1133208-42-0 | 
|
| OXL-IMP-V0002 | Vildagliptin Imp 1 | C19H27N2O6F | 436.43 | 565453-41-0 | 
|
| OXL-IMP-V0001 | Vildagliptin | C17H25N3O2 | 303.41 | 274901-16-5 | 
|
| Catalogue Number | Name of the Impurity | Molecular Formula | Molecular Weight | CAS Number | Structure |